EP
Elkhorn Partners Portfolio holdings
AUM
$138M
This Quarter Return
+0.68%
1 Year Return
+1.6%
3 Year Return
+7.74%
5 Year Return
+48.56%
10 Year Return
+43.22%
AUM
$165M
AUM Growth
+$165M
(+1.3%)
Cap. Flow
+$1.05M
Cap. Flow
% of AUM
0.64%
Top 10 Holdings %
Top 10 Hldgs %
96.78%
Holding
46
New
3
Increased
17
Reduced
11
Closed
4
Top Buys
| 1 |
Cadiz
CDZI
|
$843K |
| 2 |
JetBlue
JBLU
|
$216K |
| 3 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$214K |
| 4 |
Alibaba
BABA
|
$130K |
| 5 |
NWLI
National Western Life Group, Inc. Class A
NWLI
|
$84.4K |
Top Sells
| 1 |
Kennedy-Wilson Holdings
KW
|
$351K |
| 2 |
CTO
CTO Realty Growth
CTO
|
$210K |
| 3 |
Apple
AAPL
|
$56.6K |
| 4 |
Amgen
AMGN
|
$49K |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
$43.7K |
Sector Composition
| 1 | Real Estate | 54.2% |
| 2 | Financials | 36.93% |
| 3 | Communication Services | 3.37% |
| 4 | Technology | 1.4% |
| 5 | Utilities | 1.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Acacia Research
ACTG
$312M
| $145K | 0.09% |
21,400
+1,400
| +7% | +$9.49K |
|
27
Energy Recovery
ERII
$750M
| $99K | 0.06% |
5,200
-800
| -13% | -$15.2K |
|
|
NWLI
28
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $95K | 0.06% |
450
+400
| +800% | +$84.4K |
|
29
Viatris
VTRS
$12.3B
| $91K | 0.06% |
6,700
-500
| -7% | -$6.79K |
|
30
Cardiff Oncology
CRDF
$130M
| $90K | 0.05% |
13,500
+7,500
| +125% | +$50K |
|
31
Amazon
AMZN
$2.41T
| $76K | 0.05% |
23
+2
| +10% | +$6.61K |
|
32
Nephros
NEPH
$44M
| $75K | 0.05% |
8,500
| – | – |
|
33
Rocket Companies
RKT
$37.6B
| $43K | 0.03% |
2,700
-2,000
| -43% | -$31.9K |
|
34
MediaAlpha
MAX
$613M
| $35K | 0.02% |
1,900
+1,600
| +533% | +$29.5K |
|
35
MP Materials
MP
$11.7B
| $35K | 0.02% |
1,100
+400
| +57% | +$12.7K |
|
36
United Airlines
UAL
$34.4B
| $23K | 0.01% |
+480
| New | +$23K |
|
|
FLG
37
Flagstar Financial, Inc.
FLG
$5.33B
| $17K | 0.01% |
1,350
-650
| -33% | -$8.2K |
|
38
Jefferies Financial Group
JEF
$13.2B
| $15K | 0.01% |
400
-550
| -58% | -$20.7K |
|
39
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$304M
| $15K | 0.01% |
+800
| New | +$15K |
|
40
CRISPR Therapeutics
CRSP
$4.82B
| $14K | 0.01% |
125
| – | – |
|
41
Five Point Holdings
FPH
$391M
| $5K | ﹤0.01% |
600
| – | – |
|
|
42
Amgen
AMGN
$153B
| – | – |
-200
| Closed | -$49K |
|
43
Axalta
AXTA
$6.67B
| – | – |
-250
| Closed | -$8K |
|
44
Creative Realities
CREX
$26.4M
| $0 | ﹤0.01% |
78
| – | – |
|
45
Gilead Sciences
GILD
$140B
| – | – |
-500
| Closed | -$34K |
|
46
Nucor
NUE
$33.3B
| – | – |
-200
| Closed | -$19K |
|